Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus

Norman K. Hollenberg; Hans‐Henrik Parving; Giancarlo Viberti; Giuseppe Remuzzi; Susan Y. Ritter; Steven L. Zelenkofske; Albert Kandra; William Daley; Ricardo Rocha

doi:10.1097/hjh.0b013e328277596e

Related publications

Article2006

Abstract 426: The Diovan Reduction Of Proteinutria (Drop) Study: Albuminuria Response to High-Doses Of Valsartan in Type 2 Diabetes Mellitus

Norman K. Hollenberg, Hans‐Henrik Parving, Giancarlo Viberti, Giuseppe Remuzzi

Article2009

Antihypertensive effects of double the maximum dose of valsartan in African–American patients with type 2 diabetes mellitus and albuminuria

Norman K. Hollenberg, Dion Zappe, Xiangyi Meng, Hans‐Henrik Parving, Giancarlo Viberti, Giuseppe Remuzzi

Article2019

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial

Piero Ruggenenti, Matias Trillini, Draženka Pongrac Barlovič, Monica Cortinovis, Antonio Pisani, Aneliya Parvanova, Ilian Iliev, Barbara Ruggiero, Stefano Rota, M Aparicio, Annalisa Perna, Francesco Peraro, Olimpia Diadei, Flavio Gaspari, Fabiola Carrara, Nadia Stucchi, Davide Martinetti, Andrej Janež, Nadan Gregorič, Eleonora Riccio, Antonio Bossi, Roberto Trevisan, Paolo Manunta,

Article2005

Metformin monotherapy for type 2 diabetes mellitus

Antonio Sáenz, Inmaculada Fernandez-Esteban, A.L. Mataix, Mónica Ausejo Segura, Marta Roqué i Figuls, David Moher

Article2014

The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

Dick de Zeeuw, Blai Coll, Dennis L. Andress, John J. Brennan, Hui Tang, Mark T. Houser, Ricardo Correa‐Rotter, Donald E. Kohan, Hiddo J.L. Heerspink, Hirofumi Makino, Vlado Perkovic, Yili Pritchett, Giuseppe Remuzzi, Sheldon W. Tobe, Robert Toto, Giancarlo Viberti, Hans‐Henrik Parving